Nicholas Co Inc Wi Lowers stake in Thermo Fisher Scientific (TMO)

Thermo Fisher Scientific (TMO) : Nicholas Co Inc Wi reduced its stake in Thermo Fisher Scientific by 1.21% during the most recent quarter end. The investment management company now holds a total of 1,032,799 shares of Thermo Fisher Scientific which is valued at $152.7 Million after selling 12,690 shares in Thermo Fisher Scientific , the firm said in a disclosure report filed with the SEC on May 13, 2016.Thermo Fisher Scientific makes up approximately 3.12% of Nicholas Co Inc Wi’s portfolio.

Other Hedge Funds, Including , Susquehanna International Group Llp reduced its stake in TMO by selling 448 shares or 2.02% in the most recent quarter. The Hedge Fund company now holds 21,678 shares of TMO which is valued at $3.2 Million. Thermo Fisher Scientific makes up approx 0.01% of Susquehanna International Group Llp’s portfolio.Raymond James Associates boosted its stake in TMO in the latest quarter, The investment management firm added 7,857 additional shares and now holds a total of 89,824 shares of Thermo Fisher Scientific which is valued at $13.3 Million. Thermo Fisher Scientific makes up approx 0.05% of Raymond James Associates’s portfolio.Systematic Financial Management Lp reduced its stake in TMO by selling 9,133 shares or 85.29% in the most recent quarter. The Hedge Fund company now holds 1,575 shares of TMO which is valued at $232,927.Palisade Capital Managementnj boosted its stake in TMO in the latest quarter, The investment management firm added 14,939 additional shares and now holds a total of 20,039 shares of Thermo Fisher Scientific which is valued at $3 Million. Thermo Fisher Scientific makes up approx 0.11% of Palisade Capital Managementnj’s portfolio.Bronfman E.l. Rothschild reduced its stake in TMO by selling 176 shares or 7.62% in the most recent quarter. The Hedge Fund company now holds 2,133 shares of TMO which is valued at $313,487. Thermo Fisher Scientific makes up approx 0.06% of Bronfman E.l. Rothschild’s portfolio.

Thermo Fisher Scientific opened for trading at $150.84 and hit $151.68 on the upside on Wednesday, eventually ending the session at $151.16, with a gain of 0.32% or 0.48 points. The heightened volatility saw the trading volume jump to 13,11,933 shares. Company has a market cap of $59,483 M.

On the company’s financial health, Thermo Fisher Scientific reported $1.80 EPS for the quarter, beating the analyst consensus estimate by $ 0.06 according to the earnings call on Apr 28, 2016. Analyst had a consensus of $1.74. The company had revenue of $4294.80 million for the quarter, compared to analysts expectations of $4113.28 million. The company’s revenue was up 9.6% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.63 EPS.

Investors should note that on May 18, 2016, Thermo Fisher Scientific announced a cash dividend of $0.1500. The company’s management has announced Jun 13, 2016 as the ex-dividend date and fixed the record date on Jun 15, 2016. The payable date has been fixed on Jul 15, 2016.

Many Wall Street Analysts have commented on Thermo Fisher Scientific. Company shares were Reiterated by Mizuho on May 19, 2016 to “Buy”, Firm has raised the Price Target to $ 166 from a previous price target of $163 .Company shares were Reiterated by Mizuho on May 3, 2016 to “Buy”, Firm has raised the Price Target to $ 163 from a previous price target of $160 .Thermo Fisher Scientific was Downgraded by Jefferies to ” Hold” on Apr 29, 2016.

Thermo Fisher Scientific Inc. is a provider of analytical instruments equipment reagents and consumables software and services for research manufacturing analysis discovery and diagnostics. The company operates through four segments: Life Sciences Solutions provides reagents instruments and consumables used in biological and medical research discovery and production of new drugs and vaccines as well as diagnosis of disease; Analytical Instruments provides instruments consumables software and services that are used in the laboratory; Specialty Diagnostics offers diagnostic test kits reagents culture media instruments and associated products and Laboratory Products and Services offers self-manufactured and sourced products for the laboratory.

Leave a Reply

Thermo Fisher Scientific - Is it time to Sell?

Top Brokerage Firms are advising their investors on Thermo Fisher Scientific. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.